Senior Expert Data Scientist, Neuroscience (Dual Level Posting: I / II)
Novartis
Summary
The neuroscience disease area is looking for a data scientist or computational biologist with expertise in Neuroscience. This role will be part of a team developing novel approaches in drug discovery to tackle medical challenges and improve patient outcomes. The candidate should be able to integrate, analyze, and interpret large biomedical datasets using various computational tools. We seek a motivated, creative, and collaborative individual.
Job description
Responsibilities
- Applying established and novel approaches, including AI, to model multi-modal clinical or pre-clinical data to identify and prioritize novel targets and biomarkers.
- Work with wet lab scientists to develop testable biological hypotheses and collaborate in designing rigorous preclinical experiments.
- Collaborate with other data scientists and be a subject matter expert in analyzing in-vitro, in-vivo, and clinical data relevant to Neuroscience.
- Analyze genomics, proteomics, transcriptomics or related data from in-vitro, in-vivo, and clinical studies.
What you'll bring to the role
This is a dual level posting: Level I Requirements: Ph.D. with 2 or more years of experience in computational biology, data science, or related fields. Level II: Ph.D. with 4 or more years of experience in computational biology, data science, or related fields.
- Experience in cellular / molecular biology aspects of neuroscience, neurodegeneration, neuromuscular disorders or similar fields of biology.
- Experience in programming with Python and/or R, experience in utilizing coding agents.
- Experience in big data analytics (curation, integration, and statistical analysis of large data sets).
- Experience in processing and analyzing proteomics (Somascan, Olink, MS-based, or similar) or transcriptomics (bulk, single cell, spatial) data.
- Ability to interpret complex biological data using pathways, systems biology, biological networks or similar is a plus.
- Experience in applying deep learning/ML in the above areas is a plus.
Requirements
- Ph.D. in computational biology, data science, or related field
- 2 or more years of experience (Level I) or 4 or more years (Level II) in computational biology, data science, or related fields
- Experience in cellular / molecular biology aspects of neuroscience, neurodegeneration, neuromuscular disorders or similar fields of biology
- Experience in programming with Python and/or R
- Experience in utilizing coding agents
- Experience in big data analytics (curation, integration, and statistical analysis of large data sets)
- Experience in processing and analyzing proteomics (Somascan, Olink, MS-based, or similar) or transcriptomics (bulk, single cell, spatial) data
- Ability to interpret complex biological data using pathways, systems biology, biological networks or similar (plus)
- Experience in applying deep learning/ML in the above areas (plus)
Benefits
- Health, Life & Disability Benefits
- 401(k) Matching
- Performance-Based Cash Incentive
- Annual Equity Awards
- Vacation, Personal Days & Holidays
Company overview
Novartis is a global pharmaceutical company headquartered in Basel, Switzerland, dedicated to reimagining medicine to improve and extend people's lives. As an innovative medicines company, Novartis focuses on developing high-value treatments that address society's greatest disease burdens through technology leadership in research and development. The company operates across five core therapeutic areas: cardiovascular, renal and metabolic diseases; immunology; neuroscience; oncology; and hematology. With a workforce of approximately 75,883 employees worldwide, Novartis reaches nearly 300 million patients across 118 countries. The company leverages advanced technology platforms including targeted protein degradation, cell therapy, gene therapy, radioligand therapy, and xRNA to develop breakthrough treatments. Novartis maintains a strong portfolio of oncology drugs and generics while continuously expanding its pipeline through strategic acquisitions and internal research. The company's commitment extends beyond drug development to ensuring global access to medical innovations through novel access approaches and patient assistance programs.